| Unique ID issued by UMIN | UMIN000054568 |
|---|---|
| Receipt number | R000062340 |
| Scientific Title | Prospective Multicenter Observational Study of Disappearing Colorectal Liver Metastases |
| Date of disclosure of the study information | 2024/10/01 |
| Last modified on | 2026/01/01 15:53:45 |
Prospective Multicenter Observational Study of Disappearing Colorectal Liver Metastases
Kyoto-DLM Study
Prospective Multicenter Observational Study of Disappearing Colorectal Liver Metastases
Kyoto-DLM Study
| Japan |
colorectal liver metastases
| Surgery in general | Hepato-biliary-pancreatic surgery |
Malignancy
NO
To evaluate the negative predictive value of DLM diagnosed by EOB-MRI (3T, slice thickness of hepatobiliary phase with 2mm or less) for no residual tumor
Others
To evaluate the negative predictive value of DLM diagnosed by EOB-MRI (3T, slice thickness of hepatobiliary phase with 2mm or less) for no residual tumor
Confirmatory
Pragmatic
Not applicable
negative predictive value for no residual tumor
overall survival
intrahepatic recurrence free survival
recurrence free survival
factors predicting for no residual tumor
Observational
| 18 | years-old | <= |
| Not applicable |
Male and Female
a) Patients with synchronous colorectal liver metastases who have disappearing liver metastases (DLM) which are detected by CT and EOB-MRI (3T, slice thickness of hepatobiliary phase with 2mm or less).
b) The lesions were detected by EOB-MRI (3T, slice thickness of hepatobiliary phase with 2mm or less) before or within a month after a beginning of the chemotherapy for synchronous colorectal liver metastases.
c) Patients who underwent thoracoabdominal CECT scan before or within a month after the beginning of the chemotherapy for synchronous colorectal liver metastases.
d) RAS mutation, BRAF mutation and MSI status of a primary colorectal cancer are known or planned to be tested.
e) Patients without allergic reaction to contrast medium and can undergo EOB-MRI.
f) Patients who are expected to survive more than 6 months.
g) Patients aged 18 years or older.
h) Patients without a possibility of pregnancy.
Patients who were diagnosed with any malignant tumors other than colorectal cancer and carcinoma in situ within the past two years.
100
| 1st name | Hiroto |
| Middle name | |
| Last name | Nishino |
Kyoto University Hospital
Department of Surgery, Division of Hepato-Biliary-Pancreatic Surgery and Transplantation
606-8507
54 Kawahara-cho, Shogoin, Sakyo-ku, Kyoto, Japan
075-751-3242
hnishino@kuhp.kyoto-u.ac.jp
| 1st name | Kojiro |
| Middle name | |
| Last name | Nakamura |
National Hospital Organization Kyoto Medical Center
Department of Surgery
612-0861
1-1 Mukaihata-cho, Fukakusa, Fushimi-ku, 612-8555 Kyoto, Japan
075-641-9161
kojiro@kuhp.kyoto-u.ac.jp
Kyoto University
Other
Other
Kyoto University
54 Kawahara-cho, Shogoin, Sakyo-ku, Kyoto, Japan
075-751-3111
ethcom@kuhp.kyoto-u.ac.jp
NO
京都大学医学部附属病院(京都府)、大阪赤十字病院(大阪府)、関西電力病院(大阪府)、京都医療センター(京都府)、倉敷中央病院(岡山県)、神戸市立医療センター中央市民病院(兵庫県)、滋賀県立総合病院(滋賀県)、天理よろづ相談所病院(奈良県)、西神戸医療センター(兵庫県)、兵庫県立尼崎総合医療センター(兵庫県)、福岡大学病院(福岡県)、洛和会音羽病院(京都府)、京都桂病院(京都府)、静岡市立静岡病院(静岡県)、大阪府済生会野江病院(大阪府)、島根県立中央病院(島根県)、小倉記念病院(福岡県)
| 2024 | Year | 10 | Month | 01 | Day |
Unpublished
Open public recruiting
| 2024 | Year | 07 | Month | 01 | Day |
| 2024 | Year | 09 | Month | 18 | Day |
| 2024 | Year | 10 | Month | 01 | Day |
| 2031 | Year | 09 | Month | 30 | Day |
N/A
| 2024 | Year | 06 | Month | 04 | Day |
| 2026 | Year | 01 | Month | 01 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000062340